Zweegman S - Search Results

1

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.

Zwaginga JJ, van der Holt B, Te Boekhorst PA, Biemond BJ, Levin MD, van der Griend R, Brand A, Zweegman S, Pruijt HF, Novotny VM, Vreugdenhil A, de Groot MR, de Weerdt O, van Pampus EC, van Maanen-Lamme TM, Wittebol S, Schipperus MR, Silbermann MH, Huijgens PC, Luten M, Hollestein R, Brakenhoff JA, Schrama JG, Valster FA, Velders GA, Koene HR; Dutch HOVON 64 study group. Zwaginga JJ, et al. Among authors: zweegman s. Haematologica. 2015 Mar;100(3):e90-2. doi: 10.3324/haematol.2014.110213. Epub 2014 Nov 25. Haematologica. 2015. PMID: 25425692 Free PMC article. Clinical Trial. No abstract available.

2

[Hepatosplenic candidiasis in patients treated for hemato-oncological disorders].

Zweegman S, Sibinga L, Huijgens PC. Zweegman S, et al. Ned Tijdschr Geneeskd. 1994 Jan 1;138(1):35-8. Ned Tijdschr Geneeskd. 1994. PMID: 8289957 Dutch.

3

[Intravenous high-dose methylprednisolone efficacy for treatment of idiopathic thrombocytopenic purpura in adults].

Visser R, Zweegman S, Ossenkoppele GJ, Huijgens PC. Visser R, et al. Among authors: zweegman s. Ned Tijdschr Geneeskd. 1999 Oct 9;143(41):2053-7. Ned Tijdschr Geneeskd. 1999. PMID: 10560547 Dutch.

4

Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation.

Zweegman S, Veenhof MA, Huijgens PC, Schuurhuis GJ, Dräger AM. Zweegman S, et al. Exp Hematol. 2000 Apr;28(4):401-10. doi: 10.1016/s0301-472x(00)00128-4. Exp Hematol. 2000. PMID: 10781898 Free article.

5

Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.

Timmers GJ, Zweegman S, Simoons-Smit AM, van Loenen AC, Touw D, Huijgens PC. Timmers GJ, et al. Among authors: zweegman s. Bone Marrow Transplant. 2000 Apr;25(8):879-84. doi: 10.1038/sj.bmt.1702243. Bone Marrow Transplant. 2000. PMID: 10808210 Clinical Trial.

6

Treatment of myeloma: recent developments.

Zweegman S, Huijgens PC. Zweegman S, et al. Anticancer Drugs. 2002 Apr;13(4):339-51. doi: 10.1097/00001813-200204000-00002. Anticancer Drugs. 2002. PMID: 11984079 Review.

7

Homing and clonogenic outgrowth of CD34(+) peripheral blood stem cells: a role for L-selectin?

de Boer F, Kessler FL, Netelenbos T, Zweegman S, Huijgens PC, van der Wall E, van der Linden JA, Pinedo HM, Schuurhuis GJ, Dräger AM. de Boer F, et al. Among authors: zweegman s. Exp Hematol. 2002 Jun;30(6):590-7. doi: 10.1016/s0301-472x(02)00797-x. Exp Hematol. 2002. PMID: 12063026 Free article.

8

Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma.

Jonkhoff AR, De Kreuk AM, Franschman G, Van Der Lelie J, Schuurhuis GJ, Dräger AM, Zweegman S, Huijgens PC, Ossenkoppele GJ. Jonkhoff AR, et al. Among authors: zweegman s. Br J Haematol. 2002 Jul;118(1):90-100. doi: 10.1046/j.1365-2141.2002.03636.x. Br J Haematol. 2002. PMID: 12100131 Free article.

9

Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells.

Netelenbos T, Zuijderduijn S, Van Den Born J, Kessler FL, Zweegman S, Huijgens PC, Dräger AM. Netelenbos T, et al. Among authors: zweegman s. J Leukoc Biol. 2002 Aug;72(2):353-62. J Leukoc Biol. 2002. PMID: 12149427

10

[Management of monoclonal gammopathy].

Huijgens PC, Zweegman S. Huijgens PC, et al. Among authors: zweegman s. Ned Tijdschr Geneeskd. 2002 Jul 27;146(30):1401-2. Ned Tijdschr Geneeskd. 2002. PMID: 12174432 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page